Document Preview Unavailable

A randomized phase III study of docetaxel alone versus docetaxel plus S-1 in patients with previously treated non-small cell lung cancer: JMTO LC09-01

Atagi, Shinji; Daimon, Takashi; Okishio, Kyoichi; Komuta, Kiyoshi; Okano, Yoshio; et al.  Thoracic Cancer Vol. 14, Iss. 29,  (Oct 2023): 2941-2949.

You might have access to this document